Want to see JP:4360 full AI Analyst Report?
Top Page
MANAC Chemical Partners Co.,Ltd
(4360)
Select Model
Select Model
Rating:77Outperform
Price Target:
¥1,155.00
▲(75.00% Upside)
Action:Upgraded
Date:08/11/26
The score is driven primarily by a strong financial recovery in 2026 and a conservative balance sheet, supported by an attractive valuation (low P/E). Technicals are positive with price above key moving averages and a positive MACD, but overbought RSI raises near-term pullback risk and earnings/cash-flow volatility remains the key fundamental watch item.
Positive Factors
Revenue and Profit Recovery
The 2026 rebound shows renewed commercial momentum alongside restored operating profitability, not just revenue expansion. If sustained, stronger sales and positive EBIT/EBITDA can improve internal funding capacity and support investment in specialty chemical capabilities over the next several quarters.
Negative Factors
Earnings Volatility
The swing from strong earlier results to a large 2025 loss and then renewed 2026 profitability indicates that earnings power has not yet been demonstrated consistently through the cycle. Such volatility makes forward profit durability less certain and complicates planning and capital allocation.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue and Profit Recovery
The 2026 rebound shows renewed commercial momentum alongside restored operating profitability, not just revenue expansion. If sustained, stronger sales and positive EBIT/EBITDA can improve internal funding capacity and support investment in specialty chemical capabilities over the next several quarters.
Read all positive factors
MANAC Chemical Partners Co.,Ltd (4360) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥8.81B
Dividend Yield1.47%
Average Volume (3M)8.87K
Price to Earnings (P/E)8.4
Beta (1Y)0.91
Revenue Growth19.58%
EPS GrowthN/A
CountryJP
Employees246
SectorBasic Materials
Sector Strength58
IndustryChemicals
Share Statistics
EPS (TTM)120.54
Shares Outstanding8,625,000
10 Day Avg. Volume4,180
30 Day Avg. Volume8,873
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)0.70
Price to Sales (P/S)0.72
P/FCF Ratio14.96
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
MANAC Chemical Partners Co.,Ltd Business Overview & Revenue Model
Company Description
Operating primarily in Japan, MANAC Chemical Partners Co.,Ltd, along with its subsidiaries, undertakes the comprehensive development, manufacturing, sales, import, and export of industrial chemicals and pharmaceutical products. The company additio...
How the Company Makes Money
MANAC Chemical Partners makes money primarily by selling chemical products it manufactures to business customers (B2B). Revenue is generated through (1) product sales of specialty/fine chemicals (including functional materials and chemical interme...
MANAC Chemical Partners Co.,Ltd Financial Statement Overview
Summary
Income Statement
70
Positive
Balance Sheet
83
Very Positive
Cash Flow
67
Positive
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.48B | 10.99B | 9.30B | 9.69B | 11.85B | 10.70B |
| Gross Profit | 2.85B | 2.50B | 1.47B | 1.82B | 2.81B | 2.43B |
| EBITDA | 1.50B | 1.11B | -312.00M | 545.00M | 1.62B | 1.19B |
| Net Income | 983.00M | 781.00M | -895.00M | 82.00M | 821.00M | 712.00M |
Balance Sheet | ||||||
| Total Assets | 16.02B | 15.31B | 12.65B | 14.10B | 15.01B | 13.59B |
| Cash, Cash Equivalents and Short-Term Investments | 4.19B | 4.01B | 2.77B | 3.29B | 3.72B | 2.04B |
| Total Debt | 791.00M | 816.00M | 0.00 | 0.00 | 290.00M | 291.00M |
| Total Liabilities | 4.32B | 4.00B | 2.34B | 2.85B | 3.97B | 3.29B |
| Stockholders Equity | 11.70B | 11.30B | 10.30B | 11.25B | 11.04B | 10.29B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 531.00M | -411.00M | -593.00M | 1.40B | 30.00M |
| Operating Cash Flow | 0.00 | 2.15B | 108.00M | -118.00M | 1.65B | 714.00M |
| Investing Cash Flow | 0.00 | -1.66B | -489.00M | -231.00M | 199.00M | -422.00M |
| Financing Cash Flow | 0.00 | 727.00M | -126.00M | -75.00M | -125.00M | -200.00M |
MANAC Chemical Partners Co.,Ltd Technical Analysis
Positive
660.00
Price Trends
905.42
Positive
847.53
Positive
857.91
Positive
Market Momentum
25.91
Negative
68.82
Neutral
88.65
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4360, the sentiment is Positive. The current price of 660 is below the 20-day moving average (MA) of 975.32, below the 50-day MA of 905.42, and below the 200-day MA of 857.91, indicating a bullish trend. The MACD of 25.91 indicates Negative momentum. The RSI at 68.82 is Neutral, neither overbought nor oversold. The STOCH value of 88.65 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4360.
MANAC Chemical Partners Co.,Ltd Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥8.81B | 8.45 | ― | 1.47% | 19.58% | ― | |
77 Outperform | ¥9.48B | 2.67 | ― | 1.63% | 0.56% | 238.99% | |
73 Outperform | ¥9.55B | 11.67 | ― | 2.67% | 12.39% | 22.04% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
59 Neutral | ¥8.01B | 19.07 | ― | 2.72% | -0.78% | -41.25% | |
54 Neutral | ¥9.17B | 28.43 | ― | 0.94% | -5.34% | 113.57% |
* Basic Materials Sector Average
JP:4360
MANAC Chemical Partners Co.,Ltd
1,018.00
458.81
82.05%
JP:4040
NANKAI CHEMICAL COMPANY LIMITED
4,000.00
1,304.00
48.37%
JP:4531
Yuki Gosei Kogyo Co., Ltd.
368.00
91.99
33.33%
JP:4960
Chemipro Kasei Kaisya,Ltd.
530.00
227.28
75.08%
JP:6568
KNC Laboratories Co.,Ltd.
1,234.00
116.90
10.46%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.